Payment overview · 2025
General Payments
$23.53
1 reported records · 1 companies
Healthcare provider profile · identity verified
Darryl K Guistwite, DO
Allopathic & Osteopathic Physicians|Family Medicine · CARLISLE, PA · NPI 1609816586
Verified facts
What the public records show
CMS Open Payments records show Darryl K Guistwite, DO received $23.53 in general payments during 2025 across 1 reported records.
Novo Nordisk Inc accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Ozempic.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 49 claims for Ozempic by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $23.53 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $23.53 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Ozempic Normalized: ozempic |
Drug | Novo Nordisk Inc | $23.53 | 1 | 2025 |
Source payment records
|
|||||
| Rybelsus Normalized: rybelsus |
Drug | Novo Nordisk Inc | $23.53 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Ozempic ozempic |
2025 | Ozempic | 2024 | 49 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
49 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2048 | 128 |
| Furosemide | Furosemide | 1637 | 110 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1345 | 80 |
| Gabapentin | Gabapentin | 1318 | 73 |
| Amlodipine Besylate | Amlodipine Besylate | 1182 | 67 |
| Lisinopril | Lisinopril | 1153 | 66 |
| Pantoprazole Sodium | Pantoprazole Sodium | 1096 | 79 |
| Metoprolol Tartrate | Metoprolol Tartrate | 1067 | 60 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1019 | 55 |
| Quetiapine Fumarate | Quetiapine Fumarate | 1018 | 48 |
| Metoprolol Succinate | Metoprolol Succinate | 945 | 70 |
| Metformin Hcl | Metformin Hcl | 919 | 44 |
| Trazodone Hcl | Trazodone Hcl | 881 | 49 |
| Sertraline Hcl | Sertraline Hcl | 861 | 50 |
| Donepezil Hcl | Donepezil Hcl | 857 | 48 |
| Divalproex Sodium | Divalproex Sodium | 848 | 40 |
| Duloxetine Hcl | Duloxetine Hcl | 846 | 37 |
| Potassium Chloride | Potassium Chloride | 814 | 60 |
| Escitalopram Oxalate | Escitalopram Oxalate | 773 | 43 |
| Eliquis | Apixaban | 762 | 64 |
| Mirtazapine | Mirtazapine | 736 | 52 |
| Levetiracetam | Levetiracetam | 696 | 26 |
| Memantine Hcl | Memantine Hcl | 637 | 30 |
| Famotidine | Famotidine | 584 | 31 |
| Omeprazole | Omeprazole | 567 | 47 |
| Olanzapine | Olanzapine | 536 | 16 |
| Risperidone | Risperidone | 509 | 26 |
| Hydrochlorothiazide | Hydrochlorothiazide | 488 | 23 |
| Losartan Potassium | Losartan Potassium | 487 | 26 |
| Warfarin Sodium | Warfarin Sodium | 476 | 16 |
| Midodrine Hcl | Midodrine Hcl | 411 | 23 |
| Clopidogrel | Clopidogrel Bisulfate | 407 | 33 |
| Buspirone Hcl | Buspirone Hcl | 405 | 31 |
| Lorazepam | Lorazepam | 400 | 66 |
| Hydralazine Hcl | Hydralazine Hcl | 388 | 16 |
| Fluoxetine Hcl | Fluoxetine Hcl | 362 | 12 |
| Carvedilol | Carvedilol | 349 | 33 |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 348 | 31 |
| Allopurinol | Allopurinol | 337 | 18 |
| Amiodarone Hcl | Amiodarone Hcl | 311 | 20 |
| Bumetanide | Bumetanide | 303 | 22 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 289 | suppressed |
| Jardiance | Empagliflozin | 271 | 20 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 269 | 16 |
| Ondansetron Hcl | Ondansetron Hcl | 259 | 119 |
| Spironolactone | Spironolactone | 249 | 22 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 246 | 15 |
| Simvastatin | Simvastatin | 238 | 19 |
| Methenamine Hippurate | Methenamine Hippurate | 229 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 225 | 16 |
| Meloxicam | Meloxicam | 212 | 14 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 210 | 34 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 204 | 17 |
| Finasteride | Finasteride | 199 | 14 |
| Ropinirole Hcl | Ropinirole Hcl | 198 | 15 |
| Baclofen | Baclofen | 197 | 12 |
| Myrbetriq | Mirabegron | 194 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 181 | 35 |
| Aripiprazole | Aripiprazole | 169 | suppressed |
| Glipizide Er | Glipizide | 167 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 166 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 156 | 41 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 155 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 145 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 138 | suppressed |
| Trulicity | Dulaglutide | 138 | 12 |
| Primidone | Primidone | 137 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 135 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 132 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 129 | suppressed |
| Bupropion Xl | Bupropion Hcl | 125 | suppressed |
| Lamotrigine | Lamotrigine | 124 | suppressed |
| Januvia | Sitagliptin Phosphate | 123 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 122 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 121 | suppressed |
| Ezetimibe | Ezetimibe | 120 | suppressed |
| Cephalexin | Cephalexin | 116 | 51 |
| Xarelto | Rivaroxaban | 115 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 113 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 112 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 111 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 110 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 98 | suppressed |
| Oxycodone Hcl | Oxycodone Hcl | 95 | 23 |
| Pregabalin | Pregabalin | 91 | 11 |
| Fenofibrate | Fenofibrate | 90 | suppressed |
| Isosorbide Dinitrate | Isosorbide Dinitrate | 90 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 89 | 11 |
| Ranolazine Er | Ranolazine | 88 | suppressed |
| Loperamide | Loperamide Hcl | 86 | 36 |
| Calcitriol | Calcitriol | 82 | suppressed |
| Levemir Flexpen | Insulin Detemir | 81 | 13 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 81 | suppressed |
| Torsemide | Torsemide | 78 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 77 | 22 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 74 | 50 |
| Diclofenac Sodium | Diclofenac Sodium | 73 | 27 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 72 | 11 |
| Clonazepam | Clonazepam | 69 | suppressed |
| Glipizide | Glipizide | 67 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 66 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 66 | suppressed |
| Prednisone | Prednisone | 66 | 24 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 61 | 34 |
| Hydrocortisone | Hydrocortisone | 61 | 18 |
| Solifenacin Succinate | Solifenacin Succinate | 61 | suppressed |
| Alendronate Sodium | Alendronate Sodium | 60 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 60 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 59 | 32 |
| Methimazole | Methimazole | 58 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 52 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 52 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 52 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 52 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 51 | suppressed |
| Levofloxacin | Levofloxacin | 49 | 32 |
| Ozempic | Semaglutide | 49 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 48 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 47 | suppressed |
| Ibuprofen | Ibuprofen | 47 | 12 |
| Venlafaxine Hcl | Venlafaxine Hcl | 47 | suppressed |
| Novofine Autocover | Pen Needle, Diabetic, Safety | 46 | 15 |
| Clonidine | Clonidine | 45 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 44 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 44 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 44 | suppressed |
| Lansoprazole | Lansoprazole | 43 | suppressed |
| Brilinta | Ticagrelor | 42 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 42 | 12 |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 41 | 41 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 40 | 30 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 40 | 11 |
| Insulin Aspart Flexpen | Insulin Aspart | 39 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 39 | 28 |
| Bupropion Hcl | Bupropion Hcl | 38 | suppressed |
| Lactulose | Lactulose | 38 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 38 | suppressed |
| Atenolol | Atenolol | 37 | suppressed |
| Glimepiride | Glimepiride | 37 | suppressed |
| Oxycontin | Oxycodone Hcl | 37 | suppressed |
| Xifaxan | Rifaximin | 37 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 37 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 36 | 19 |
| Farxiga | Dapagliflozin Propanediol | 36 | suppressed |
| Linzess | Linaclotide | 36 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 36 | suppressed |
| Metolazone | Metolazone | 35 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 35 | suppressed |
| Morphine Sulfate | Morphine Sulfate | 34 | 25 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 34 | 23 |
| Nystatin | Nystatin | 34 | 21 |
| Amantadine | Amantadine Hcl | 33 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 33 | suppressed |
| Anastrozole | Anastrozole | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 32 | suppressed |
| Tradjenta | Linagliptin | 32 | suppressed |
| Ursodiol | Ursodiol | 32 | suppressed |
| Lumigan | Bimatoprost | 31 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 30 | 15 |
| Silodosin | Silodosin | 30 | suppressed |
| Lovastatin | Lovastatin | 29 | suppressed |
| Polymyxin B Sul-Trimethoprim | Polymyxin B Sulf/Trimethoprim | 29 | 21 |
| Doxycycline Hyclate | Doxycycline Hyclate | 28 | 13 |
| Meropenem | Meropenem | 28 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 27 | 18 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 27 | 22 |
| Alprazolam | Alprazolam | 26 | suppressed |
| Latanoprost | Latanoprost | 26 | suppressed |
| Nexium | Esomeprazole Magnesium | 26 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 24 | 19 |
| Azelastine Hcl | Azelastine Hcl | 24 | suppressed |
| Carbamazepine | Carbamazepine | 24 | suppressed |
| Nyamyc | Nystatin | 24 | 16 |
| Celecoxib | Celecoxib | 23 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 23 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 23 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 22 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 22 | suppressed |
| Sucralfate | Sucralfate | 22 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 21 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 21 | suppressed |
| Mirabegron Er | Mirabegron | 21 | suppressed |
| Digoxin | Digoxin | 20 | suppressed |
| Humalog Mix 75-25 Kwikpen | Insulin Lispro Protamin/Lispro | 20 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 19 | 15 |
| Irbesartan | Irbesartan | 19 | suppressed |
| Levemir | Insulin Detemir | 19 | suppressed |
| Nitroglycerin | Nitroglycerin | 19 | 17 |
| Repaglinide | Repaglinide | 19 | suppressed |
| Advair Diskus | Fluticasone Propion/Salmeterol | 18 | suppressed |
| Fluconazole | Fluconazole | 18 | 13 |
| Ammonium Lactate | Ammonium Lactate | 17 | suppressed |
| Amoxicillin | Amoxicillin | 17 | suppressed |
| Daptomycin | Daptomycin | 17 | suppressed |
| Novolog Flexpen | Insulin Aspart | 17 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 17 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 16 | 16 |
| Azithromycin | Azithromycin | 16 | 12 |
| Colchicine | Colchicine | 16 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 16 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 16 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 16 | suppressed |
| Mupirocin | Mupirocin | 16 | 14 |
| Sodium Chloride | 0.9 % Sodium Chloride | 16 | 14 |
| Humulin R U-500 Kwikpen | Insulin Regular, Human | 15 | suppressed |
| Ondansetron Odt | Ondansetron | 15 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 15 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 14 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 14 | suppressed |
| Haloperidol | Haloperidol | 14 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 14 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 13 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 13 | suppressed |
| Humalog Mix 75-25 | Insulin Lispro Protamin/Lispro | 13 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 13 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 13 | suppressed |
| Valsartan-Hydrochlorothiazide | Valsartan/Hydrochlorothiazide | 13 | suppressed |
| Calcium Acetate | Calcium Acetate | 12 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 12 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 12 | suppressed |
| Clotrimazole | Clotrimazole | 12 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 12 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 12 | suppressed |
| Lacosamide | Lacosamide | 12 | suppressed |
| Restasis | Cyclosporine | 12 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 12 | suppressed |
| Tetrabenazine | Tetrabenazine | 12 | suppressed |
| Timolol Maleate | Timolol Maleate | 12 | suppressed |
| Bisoprolol Fumarate | Bisoprolol Fumarate | 11 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Fosfomycin Tromethamine | Fosfomycin Tromethamine | 11 | suppressed |
| Levocarnitine | Levocarnitine | 11 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 11 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 11 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 11 | suppressed |
| Rivastigmine | Rivastigmine | 11 | suppressed |
| Semglee (Yfgn) Pen | Insulin Glargine-Yfgn | 11 | suppressed |
| Topiramate | Topiramate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $23.53 · 1 records | Novo Nordisk Inc | Ozempic, Rybelsus | 1 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Ozempic play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with Novo Nordisk Inc?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error